Volume 23, Number 3—March 2017
Dispatch
Disseminated Nontuberculous Mycobacteria in HIV-Infected Patients, Oregon, USA, 2007–2012
Cara D. Varley
, Jennifer H. Ku, Emily Henkle, Sean D. Schafer, and Kevin L. Winthrop
, Jennifer H. Ku, Emily Henkle, Sean D. Schafer, and Kevin L. Winthrop
Table 1
Characteristics of 37 patients with HIV and disseminated NTM infection, Oregon, USA, 2007–2012*
| Variable |
Value |
| Race | |
| White | 26 (70.3) |
| Black | 6 (16.2) |
| Asian, Native American, Alaskan Native, Pacific Islander, >1 race | 5 (13.5) |
| Hispanic |
8 (21.6) |
| Female sex |
9 (24.3) |
| Age at disseminated NTM diagnosis, y, median (range) | 40 (22.7–59.4) |
| Deceased at time of data analysis |
19 (52.8) |
| Time from HIV diagnosis to NTM diagnosis, y, median (range) |
2.1 (0–20.7) |
| NTM species | |
| M. aubagnense | 1 (2.7) |
| M. avium | 35 (94.6) |
| M. chelonae |
1 (2.7) |
| CD4 count, cells/mm3)† | 10 (1–414) |
| <50 | 23 (74.2) |
| 50–100 | 5 (16.1) |
| 101–200 | 1 (3.2) |
| >200 |
2 (6.5) |
| Viral load, copies/mL, median (range) | 131,446 (0–4,570,000) |
*Values are no. (%) except as indicated. NTM, nontuberculous mycobacteria.
†CD4 count missing for 6 patients.
Page created: February 17, 2017
Page updated: February 17, 2017
Page reviewed: February 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.